Concentrix Corporation Profile Avatar - Palmy Investing

Concentrix Corporation

Concentrix Corporation provides technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services. It a…
Information Technology Services
US, Fremont [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 33% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -17.90 28.33 34.51
Graham Fair Price -18.86 33.39 41.15
PEG 5.83 -0.74 -0.78
Price/Book -17.33 1.16 1.40
Price/Cash Flow 30.76 -46.22 35.35
Prices/Earnings 9.15 22.83 20.91
Price/Sales -24.02 1.98 2.61
Price/FCF 30.76 -46.22 35.35
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -24.18 0.28 0.37
Operating Margin -8.40 0.07 0.08
ROA -23.49 < 0.005 < 0.005
ROE 0.02 0.01 -24.26
ROIC 0.02 0.01 -24.06
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.20 0.24 -18.88
Dividends QOQ 0.19 -0.06 -70.03
EBIT QOQ 0.11 -0.01 -88.07
EPS QOQ -0.27 -0.31 -15.91
FCF QOQ -0.02 -1.63 -8884.04
Revenue QOQ 0.37 0.08 -78.95
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 14.14 0.00 inf
Days Sales Outstanding (DSO) 76.21 72.20 -5.25
Inventory Turnover 6.37 0.00 inf
Debt/Capitalization 0.54 0.56 3.38
Quick Ratio 1.05 1.32 24.93
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 66.99 62.46 -6.76
Cash 4.78 6.37 33.29
Capex -1.05 -0.85 18.54
Free Cash Flow 2.66 -1.57 -41.05
Revenue 36.07 36.59 1.45
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.38 1.56 13.22
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 15.33 15.19 -0.90
Naive Interpretation Member
06 - Financial Health · Weak
End of CNXC's Analysis
CIK: 1803599 CUSIP: 20602D101 ISIN: US20602D1019 LEI: - UEI: -
Secondary Listings
CNXC has no secondary listings inside our databases.